Enrolment of about 10,500 participants in the phase III clinical trial of the indigenous one-shot Panacea Biotec developed ...

The new WHO guidelines offer evidence-based protocols for managing dengue, chikungunya, Zika and yellow fever, aiming to ...

Phase-III trial of indigenous one-shot dengue vaccine by Panacea Biotec shows promising results in India, aiming for completion by October.

The phase III clinical trial enrolment for India's first one-shot dengue vaccine, DengiAll, developed by Panacea Biotec, is set to complete with 10,500 participants across 20 centers. This trial aims ...

Enrolment of about 10,500 participants in the phase III clinical trial of the indigenous one-shot Panacea Biotec developed dengue vaccine, DengiAll, is likely to be completed by October across 20 ...

ICMR and Panacea Biotec conduct third phase trials for indigenous dengue vaccine in India with promising results.

Dengue cases in the country dropped to 32,299 between January 1 and July 5 this year, compared to 78,068 cases during the ...

WHO has issued guidelines to tackle the arbovirus diseases, which continue to be a major threat to life. Read on to know it ...

Dengue, an Aedes mosquito-borne viral infection, has been a crucial public health concern during the monsoon in our country ...

In light of the recent spell of monsoon rains, Punjab Health Ministers Khawaja Salman Rafique and Khawaja Imran Nazir have stressed the need for immediate and emergency measures to prevent the spread ...

Dengue cases in the country dropped to 32,299 between Jan 1 and July 5 this year, compared to 78,068 cases during the same ...

DHAKA, July 12, 2025 (BSS) - Health officials today said they recorded 391 fresh cases of dengue onslaughts killing at least ...